Literature DB >> 21626260

Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders.

Victor Peralta1, Virginia Basterra, Maria S Campos, Elena García de Jalón, Lucía Moreno-Izco, Manuel J Cuesta.   

Abstract

Spontaneous Parkinsonism (SP) in schizophrenia-related disorders is poorly characterized. The objective of this study was to examine the concordance and clinical validity of alternative definitions of SP in patients with nonaffective psychotic disorders. Two-hundred drug-naive patients with nonaffective psychotic disorders were examined for core parkinsonian signs, including bradykinesia, rigidity, and tremor, and diagnosed of SP according to the Simpson-Angus Scale (SAS) cutoff criterion, the UK Parkinson's disease brain bank (UKPDBB) criteria, the National Institute of Neurological Disorders and Stroke (NINDS) criteria, and criteria requiring the presence of all three core features (full syndrome criteria). Parkinsonian signs and criteria were examined in relation to a number of relevant clinical variables. The most frequent sign was rigidity (33.5%) followed by bradykinesia (16%) and tremor (12%). The prevalence rate of SP according to the SAS cutoff criterion, the UKPDBB criteria, the NINDS criteria for possible and probable SP, and the full syndrome criteria were 20.5, 13, 25.5, 18.5, and 4%, respectively. Bradykinesia was specifically related to negative symptoms, rigidity to neurological soft signs, and tremor to dyskinetic movements. The set of criteria showing more associations with clinical variables were the NINDS criteria for probable SP. Patients fulfilling these criteria had higher ratings for poor premorbid adjustment, negative symptoms, dyskinesia, neurological soft signs, and poor global treatment response than those without that diagnosis. The NINDS criteria for probable SP, i.e., presence of any two of the three core parkinsonian signs, seem to be the most suitable for clinical and research purposes.

Entities:  

Mesh:

Year:  2011        PMID: 21626260     DOI: 10.1007/s00406-011-0219-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  37 in total

1.  An abbreviated form of the Phillips Rating Scale of Premorbid Adjustment in Schizophrenia.

Authors:  J G Harris
Journal:  J Abnorm Psychol       Date:  1975-04

2.  Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.

Authors:  Jacqueline Hoeppner; Lara Prudente-Morrissey; Sabine Christiane Herpertz; Reiner Benecke; Uwe Walter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

Review 3.  Studies of individuals with schizophrenia never treated with antipsychotic medications: a review.

Authors:  E Fuller Torrey
Journal:  Schizophr Res       Date:  2002-12-01       Impact factor: 4.939

4.  Midbrain dopamine D2/3 receptor binding in schizophrenia.

Authors:  Heli Tuppurainen; Jyrki T Kuikka; Mikko P Laakso; Heimo Viinamäki; Minna Husso; Jari Tiihonen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  The effect of antipsychotic medication on neuromotor abnormalities in neuroleptic-naive nonaffective psychotic patients: a naturalistic study with haloperidol, risperidone, or olanzapine.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

8.  The motor disorders of severe psychiatric illness: a conflict of paradigms.

Authors:  D Rogers
Journal:  Br J Psychiatry       Date:  1985-09       Impact factor: 9.319

9.  A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.

Authors:  H J Möller; H Müller; R L Borison; N R Schooler; G Chouinard
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

Review 10.  Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology.

Authors:  Peter F Whitty; Olabisi Owoeye; John L Waddington
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

View more
  9 in total

1.  A Neural Signature of Parkinsonism in Patients With Schizophrenia Spectrum Disorders: A Multimodal MRI Study Using Parallel ICA.

Authors:  Robert C Wolf; Mahmoud Rashidi; Stefan Fritze; Katharina M Kubera; Georg Northoff; Fabio Sambataro; Vince D Calhoun; Lena S Geiger; Heike Tost; Dusan Hirjak
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

2.  Extrapyramidal examinations in psychiatry.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Innov Clin Neurosci       Date:  2012-07

3.  Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study.

Authors:  Manuel J Cuesta; Ana M Sánchez-Torres; Elena García de Jalón; Maria S Campos; Berta Ibáñez; Lucía Moreno-Izco; Víctor Peralta
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

4.  Low physical activity is associated with two hypokinetic motor abnormalities in psychosis.

Authors:  Sebastian Walther; Irena Vladimirova; Danai Alexaki; Lea Schäppi; Kathrine S F Damme; Vijay A Mittal; Stewart A Shankman; Katharina Stegmayer
Journal:  J Psychiatr Res       Date:  2021-11-08       Impact factor: 4.791

5.  Neurobiology of schizophrenia: from outcome to pathophysiological insights.

Authors:  P Falkai; H-J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03       Impact factor: 5.270

6.  Neurological Soft Signs, Spontaneous and Treatment Emergent Extrapyramidal Syndromes in Black Africans With First Episode Schizophrenia.

Authors:  Akin Ojagbemi; Bonga Chiliza; Toyin Bello; Laila Asmal; Oluyomi Esan; Robin Emsley; Oye Gureje
Journal:  Front Psychiatry       Date:  2018-05-01       Impact factor: 4.157

7.  Stability of Action and Kinesthetic Perception in Parkinson's Disease.

Authors:  Joseph Ricotta; Mark L Latash
Journal:  J Hum Kinet       Date:  2021-01-29       Impact factor: 2.193

8.  Characterizing the sensorimotor domain in schizophrenia spectrum disorders.

Authors:  Robert C Wolf; Dusan Hirjak; Stefan Fritze; Fabio Sambataro; Katharina M Kubera; Geva A Brandt; Andreas Meyer-Lindenberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-11-27       Impact factor: 5.760

9.  Structural alterations in brainstem, basal ganglia and thalamus associated with parkinsonism in schizophrenia spectrum disorders.

Authors:  Robert C Wolf; Dusan Hirjak; Stefan Fritze; Anais Harneit; John L Waddington; Katharina M Kubera; Mike M Schmitgen; Marie-Luise Otte; Lena S Geiger; Heike Tost; Andreas Meyer-Lindenberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-05-05       Impact factor: 5.270

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.